King Pharmaceuticals Company Description
King Pharmaceuticals may not be the monarch of US drug market, but there are a few therapeutic kingdoms it would like to rule. The firm makes branded drugs in several niche markets, including neuroscience and critical care. Its best-seller has been cardiovascular drug Altace, but when the drug unexpectedly lost patent protection in 2007, King shifted its focus onto other products, including insomnia drug Sonata and muscle relaxant Skelaxin, as well as a portfolio of primary care antibiotics and hospital-administered drugs. The company also contracts its excess manufacturing capacity to outside drug companies. Its Meridian Medical Technologies subsidiary makes the EpiPen, a pre-filled auto-injection device.
View the Comprehensive Company Description for King Pharmaceuticals
The Company Description provides a historical perspective of King Pharmaceuticals's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of King Pharmaceuticals's evolution in the marketplace.
